SECTION FOR 406 IPC - AN OVERVIEW

secobarbital will decrease the level or effect of cannabidiol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Closely. Consider a rise in cannabidiol dosage (determined by clinical reaction and tolerability) when coadministered with a solid CYP3A4 inducer.secobarbital will minimize the level or effect of da